The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Use of the Quorum‐Sensing Inhibitor RNAIII‐Inhibiting Peptide to Prevent Biofilm Formation In Vivo by Drug‐Resistant Staphylococcus epidermidis
Open accessAbstract
Staphylococcus epidermidis is a frequent cause of infections associated with foreign bodies and indwelling medical devices. The bacteria are capable of surviving antibiotic treatment through encapsulation into biofilms. RNAIII-inhibiting peptide (RIP) is a heptapeptide that inhibits S. aureus pathogenesis by disrupting quorum-sensing mechanisms. In this study, RIP inhibited drug-resistant S. epidermidis biofilm formation through a mechanism similar to that evidenced for S. aureus. RIP is synergistic with antibiotics in eliminating 100% of graft-associated in vivo S. epidermidis infections, which suggests that RIP may be used to coat medical devices to prevent staphylococcal infections. Disruption of cell-cell communication can prevent infections associated with antibiotic-resistant strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gottenbos, B. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.7 · Cited by 587
Cited by
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318
Quorum sensing inhibitors: An overview
Kalia, V. C. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.10.004 · Cited by 971
Otto, M. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75418-3_10 · Cited by 865
The application of biofilm science to the study and control of chronic bacterial infections
Costerton, W. J., Veeh, R., Shirtliff, M. E., Pasmore, M. E., Post, C., & Ehrlich, G. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20365 · Cited by 649
The application of biofilm science to the study and control of chronic bacterial infections
Costerton, W., Veeh, R., Shirtliff, M., Pasmore, M., Post, C., & Ehrlich, G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320365 · Cited by 630
Quorum sensing and swarming migration in bacteria
Daniels, R., Vanderleyden, J., & Michiels, J. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2003.09.004 · Cited by 622
Bacterial adherence and biofilm formation on medical implants: A review
Veerachamy, S., Yarlagadda, T., Manivasagam, G., & Yarlagadda, P. K. (2014) · Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine · doi:10.1177/0954411914556137 · Cited by 583
Role of biofilm in catheter-associated urinary tract infection☆
Trautner, B. W., & Darouiche, R. O. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.08.005 · Cited by 455
Del Pozo, J. L. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1417036 · Cited by 453
Innate and Induced Resistance Mechanisms of Bacterial Biofilms
Anderson, G. G., & O'Toole, G. A. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75418-3_5 · Cited by 438
Biofilm Theory Can Guide the Treatment of Device-Related Orthopaedic Infections
Costerton, J. W. (2005) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200508000-00003 · Cited by 420
Osteomyelitis and the role of biofilms in chronic infection
Brady, R. A., Leid, J. G., Calhoun, J. H., Costerton, J. W., & Shirtliff, M. E. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00357.x · Cited by 400
Biofilms and Antimicrobial Resistance
Patel, R. (2005) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000175714.68624.74 · Cited by 390
Therapeutic strategies to combat antibiotic resistance
Brooks, B. D., & Brooks, A. E. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.027 · Cited by 367
Microplate Alamar Blue Assay for Staphylococcus epidermidis Biofilm Susceptibility Testing
Pettit, R. K., Weber, C. A., Kean, M. J., Hoffmann, H., Pettit, G. R., Tan, R., Franks, K. S., & Horton, M. L. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2612-2617.2005 · Cited by 334
Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective
Rémy, B., Mion, S., Plener, L., Elias, M., Chabrière, E., & Daudé, D. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00203 · Cited by 332
The role of bacterial biofilm in persistent infections and control strategies
Chen, L., & Wen, Y. (2011) · International Journal of Oral Science · doi:10.4248/ijos11022 · Cited by 276
Etiology of Implant Orthopedic Infections: A Survey on 1027 Clinical Isolates
Arciola, C. R., An, Y. H., Campoccia, D., Donati, M. E., & Montanaro, L. (2005) · The International Journal of Artificial Organs · doi:10.1177/039139880502801106 · Cited by 274
Bacterial biofilms: a diagnostic and therapeutic challenge
Fux, C. A., Stoodley, P., Hall-Stoodley, L., & Costerton, J. W. (2003) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.1.4.667 · Cited by 269
Combating Implant Infections: Shifting Focus from Bacteria to Host
Amin Yavari, S., Castenmiller, S. M., van Strijp, J. A. G., & Croes, M. (2020) · Advanced Materials · doi:10.1002/adma.202002962 · Cited by 257
Prevention of catheter-associated urinary tract infection
Trautner, B. W., Hull, R. A., & Darouiche, R. O. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200502000-00007 · Cited by 99
de Oliveira, A., Pinheiro-Hubinger, L., Pereira, V. C., Riboli, D. F. M., Martins, K. B., Romero, L. C., & Cunha, M. D. L. R. D. S. D. (2021) · Antibiotics · doi:10.3390/antibiotics10070879 · Cited by 10
Metadata
- Authors
- Balaban, N., Giacometti, A., Cirioni, O., Gov, Y., Ghiselli, R., Mocchegiani, F., Viticchi, C., Del Prete, M. S., Saba, V., Scalise, G., & Dell’Acqua, G.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-02-15
- Volume
- 187
- Issue
- 4
- Pages
- 625-630
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2118801485
- Cited by
- 173
- References
- 1
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.